Abstract: Described is a method for treating and/or preventing vestibulodynia by administering a therapeutically effective amount of a composition to a subject in need thereof The composition can include at least one non-ionic cellulose ether being hydroxypropylmethylcellulose (HPMC), one or more pH regulating agent(s) that includes a lactate and/or a citrate buffer , and water. The composition can have a pH from 3 to 5, a viscosity from 35000 to 100 000 mPas, said viscosity being measured at 20° C. according to European Pharmacopeia 7.0, 2.210, and being free from any additional active pharmaceutical agent, wherein the composition includes from 1 wt % to 5 wt % of said non-ionic cellulose ether based on the total weight of the composition.

Abstract: The present document is directed to a pharmaceutical composition comprising: at least one non-ionic cellulose ether, one or more pH regulating agent(s), and an aqueous solvent, said composition having a pH from 3 to 5, a viscosity from 35000 to about 100 000 mPas and being free from any additional active pharmaceutical agent for use in the treatment and/or prevention of vestibulodynia.

Abstract: The present document is directed to a pharmaceutical composition comprising at least one non-ionic cellulose ether, wherein said composition has a viscosity of 35000 cP or more, an osmolality of from about 10 to about 300 mOsmol/kg, and a pH of from about 3 to about 4. The composition may be used in the treatment and/or prevention of a climacteric disorder, wherein said climacteric disorder is a selected from the group consisting of vaginal dryness, vaginal irritation, vaginal itching, dysuria, dyspareunia, and/or vaginal bleeding during and/or after sexual intercourse and any combination thereof.

Abstract: The present document is directed to a pharmaceutical composition comprising at least one non-ionic cellulose ether, wherein said composition has a viscosity of 35000 cP or more, an osmolality of from about 10 to about 300 mOsmol/kg, and a pH of from about 3 to about 4. The composition may be used in the treatment and/or prevention of a climacteric disorder, wherein said climacteric disorder is a selected from the group consisting of vaginal dryness, vaginal irritation, vaginal itching, dysuria, dyspareunia, and/or vaginal bleeding during and/or after sexual intercourse and any combination thereof.

Abstract: A method of producing immunoglobulin-rich milk, including colostrum, in mammalian mothers, is described. The method includes administration of an effective daily dosage of a preparation containing at least one type of xanthophylls, such as astaxanthin, to said mothers, e.g. cows. Immunoglobulin-rich milk, including colostrum, produced according to the method and immunoglobulin concentrates derived from such milk, including colostrum, are also disclosed. These products may be used as nutrient for mammals, and as raw material for diagnostics, human and veterinary medicines, dermatologic preparations and cosmetics industry.

Abstract: A method of prophylactic treatment of mastitis in mammalian, including human, mothers, is described. The method comprises administration of a prophylactically effective dosage of a human or veterinary medicament containing at least one type of xanthophylls, such as astaxanthin, to said mothers. Preferably, the astaxanthin exists in a form esterified with fatty acids, e.g. in the form of algae meal produced by culturing of the alga Haematococcus sp. Further, use of at least one type of xanthophylls, such as astaxanthin, for the preparation of a human or veterinary medicament for the prophylactic treatment of mastitis is mammalian, including human, mothers is disclosed.

Abstract: A method of increasing the production of/in breeding and production mammals by administering an agent which consists of at least one type of xanthophylles, preferably astaxanthin, in the feed to animals, is disclosed.

Abstract: The present invention discloses a method of increasing the production of/in breeding and production animals in the poultry industry by administering an agent which consists of at least one type of xanthophylles, preferably astaxanthin, in the feed to animals.